Connect with us

breaking news

NY bans sale of caffeine-infused cannabis – The New York Office of Cannabis Management issued a stop order to Hudson Cannabis

Published

on


1906 sells two different “drops,” or pills, with low doses of THC and higher amounts of caffeine marketed as “Go” and “Genius” in small cylinder containers.

The firm’s “Go” drops contain 80 milligrams of caffeine and 2 mgs of THC-extract and 5 mgs of cannabidiol [CBD]/ weed extract and other plant-based or herbal ingredients. Go is marketed as an energy stimulant.

Its Genius pills contain 20 mgs of caffeine mixed with 2.5 mgs of TCH and 5 mgs combined of CBD and Cannabigerol (CBG), also found in the marijuana plant, and other herbal or plant extracts. It’s touted as a “brain power” supplement to boost focus and memory and calmness.

The 1906 cannabis pills have been marketed in New York since February of last year.

But OCM regulators issued a “quarantine,” or stop order, for the 1906 tablet July 24 after inspecting the 1906 combined cannabis-caffeine mix products at the Hudson Cannabis facility.

“Evidence supports that ingredients used in product are not allowed to be used in cannabis products,” said the quarantine order signed by inspectors Natalie DeLong and Matthew Hinken.

The order said the mixed ingredients “may jeopardize public health or safety.”

The company marketing 1906, which has been sold in seven states including New York, is appealing the ruling banning the sale of $1 million of its inventory in New York.

“Hudson Cannabis and our production facilities fully follow New York State’s cannabis regulations,” said Melany Dobson, co-founder of Hudson Cannabis, in a statement to The Post on Sunday.

“We are surprised by this decision from the State to quarantine products that have been on the market for over 18 months, are sold legally in States across the nation, and as far as we know have had zero reported adverse effects.

“This type of arbitrary and capricious behavior, preventing the sale of safe and tested products readily available across the country, only serves to benefit the illicit market Governor Hochul claims to care about shutting down,” Dobson said.

A lawyer for 1906’s parent firm Nuka Enterprises, Matthew Schweber, said OCM cited what he described as a wacky decaffeination rule that forbids infusing pure caffeine into cannabis products but allows “naturally occurring caffeine.”

The rule states,  “A processor is prohibited from processing any products which… contain any non-phytocannabinoid ingredient that would increase potency, toxicity, or addictive potential, or that would create an unsafe combination, known or unknown, with other psychoactive substances. This prohibition shall not apply to products containing naturally occurring caffeine, such as coffee, tea, or chocolate.”

OCM claims that caffeine increases “potency, toxicity, or addictive potential or… create(s) an unsafe combination [with cannabinoids],” Schweber said.

“But OCM can’t say which prohibition exactly caffeine triggers? Does caffeine increase cannabis’ ‘potency?’ Does it increase its ‘toxicity’ or its ‘addictive potential?’  Does it create ‘an unsafe combination?’ ” Schweber said.

“They can’t say. Do they have documented evidence of any of the dangers of combining caffeine and cannabis? No, of course not,” the lawyer said.

Schweber said the “crazy” part is that state regulators don’t explain why “naturally occurring caffeine” is OK but added caffeine is not.

Read more https://nypost.com/2024/10/27/us-news/ny-bans-sale-of-caffeine-infused-cannabis/



Source link

Continue Reading

breaking news

Press Release: Health Canada releases new data on cannabis use in Canada – “18% of people who had used cannabis in the past 12 months reported driving after cannabis use, a significant decline from 27% in 2018.”

Published

on

By


The 2024 Canadian Cannabis Survey provides important insights into Canadians’ knowledge, attitudes and behaviours on cannabis use

December 6, 2024 | Ottawa, Ontario | Health Canada

An important part of the Government of Canada’s public health approach to legalizing and strictly regulating cannabis is ongoing and comprehensive surveillance, data collection and evidence gathering. The results from the annual Canadian Cannabis Survey provide a snapshot of public health and public safety data on cannabis in Canada.

Today, Health Canda published the 2024 Canadian Cannabis Survey (CCS) results. The data was collected from April 4th to July 2nd, 2024.

Since 2017, Health Canada has conducted the annual Canadian Cannabis Survey to better understand attitudes and knowledge regarding cannabis, as well as patterns of cannabis use in Canada. Through the information gathered, Health Canada can better understand where support is needed the most and develop program initiatives that will help educate and raise awareness around the use of cannabis.

Findings from the 2024 survey include:

  • The proportion of people in Canada who report smoking cannabis continues to decline. That said, smoking remains the most common method of consuming cannabis (69%), followed by eating (57%) and vaporizing with a vape pen or e-cigarette (37%).
  • The number of respondents who reported getting cannabis from a legal source in 2024 was 72% – an increase from 37% in 2019 to 72% in 2024, with legal storefronts being the most common source since 2019. A smaller proportion reported accessing cannabis through illegal sources (3%) compared to 2019 (16%).
  • 18% of people who had used cannabis in the past 12 months reported driving after cannabis use, a significant decline from 27% in 2018.
  • There was no change in rates of cannabis use among youth (age 16-19) over the past year. Past 12-month cannabis use among youth aged 16-19 was 41%, similar to several previous years (44%, 44%, and 43% in 2019, 2020 and 2023 respectively).
  • Overall, the proportion of respondents who said they used cannabis and reported daily, or almost daily use has been stable since 2018 (approx. 25%), including among youth (approx. 20%).
  • The percentage of people in Canada who said they use cannabis who are ‘at high risk’ of developing problems from cannabis use has remained stable since 2018 (approx. 3%).

Health Canada has made significant investments to educate youth and young adults about the health risks of cannabis, as they are at an increased risk of experiencing adverse effects from cannabis use since the brain continues to develop up until around the age of 25. These efforts include the Spring 2022 Reduce your risk: Choose legal cannabis public education campaign, the Prevention of Accidental Paediatric Cannabis Poisonings among Children campaign in Spring 2023, and the Pursue Your Passion: A Teen Cannabis Education Program, which was re-launched in March 2023 as a virtual program to educate youth and young adults about the health effects of cannabis. The department has also produced public education material that emphasizes the importance of storing cannabis securely away from children and pets.



Source link

Continue Reading

breaking news

Marijuana Moment: GOP Leaders Blocked Schumer’s Push To Include Cannabis Banking Reform In Government Funding Bill, Senate Source Says

Published

on

By


MM write

Republican House and Senate leadership “openly and solely blocked” Senate Majority Leader Chuck Schumer’s (D-NY) attempt to include bipartisan marijuana banking legislation in a government funding bill, a Senate source familiar with the negotiations tells Marijuana Moment.

As bicameral lawmakers have worked to put together a continuing resolution to keep the government funded, Schumer repeatedly urged colleagues across the aisle to incorporate the Secure and Fair Enforcement Regulation (SAFER) Banking Act, to no avail. Senate Minority Leader Mitch McConnell (R-KY) and House Speaker Mike Johnson (R-LA) killed that prospective deal, the source said.

“Schumer pushed for SAFER Banking at the negotiation table in the CR multiple times. This week, both Speaker Johnson and Leader McConnell strongly rejected it,” they said. “For years some Republicans have done a dance telling marijuana businesses that they supported SAFER, while Republican leadership has openly and solely blocked it at every turn.”

GOP Leaders Blocked Schumer’s Push To Include Marijuana Banking Reform In Government Funding Bill, Senate Source Says



Source link

Continue Reading

breaking news

Brazil: Parliamentary Front of Medicinal Cannabis and Industrial Hemp Announce Funded Cannabis Projects

Published

on

By


The Parliamentary Front of Medicinal Cannabis and Industrial Hemp held the last meeting of 2024 in the Plenary Dom Pedro I, in the Legislative Assembly of Sao Paulo (Alesp). On the occasion, the eight winning projects of the 2nd edict of parliamentary amendments, defined by the Deliberative Council of the Front, were  announced.

Sechat

State deputies Caio France and Eduardo Suplicy, coordinator and deputy coordinator of the Front, allocated R$ 1 million from the 2025 budget of individual tax amendments to finance the initiatives. Each parliamentarian contributed R$ 500 thousand, encouraging projects covering medical cannabis and industrial hemp.

Projects selected by universities and third sector entities

Of the more than 30 projects enrolled, half were submitted by public universities, such as Unicamp, Unesp and Unifesp, while the rest came from third sector organizations, city halls and state institutions. The requested values varied between R$ 50 thousand and R$ 500 thousand, with proposals covering production of informative materials, clinical studies, congresses and development of technologies related to medical cannabis.

Among the themes of the projects, we highlight studies on chronic pain, online training courses, evaluations of cannabis use in people with Autism Spectrum Disorder (ASD), and the creation of digital platforms with data on therapeutic responses.

Legislative advances and national impact

Deputy Caio France celebrated the advances made in 2024, such as the inclusion of cannabis in the Brazilian Pharmacopoeia and the decision of the Superior Court of Justice (STJ) allowing the cultivation of hemp for medicinal, pharmaceutical and industrial purposes. “State law 17,618/23 was instrumental in driving these changes. The discussions held at the meetings of the Parliamentary Front served as a guide in the selection of projects,” highlighted France.

How to follow up on the ad

The audience will be broadcast live on the Alesp Network channel on YouTube, and the results will be available on the official website of the Parliamentary Front (www.fpcannabis.co.uk).

https://sechat.com.br/noticia/frente-parlamentar-da-cannabis-medicinal-divulga-projetos-selecionados-em-edital-de-2024?utm_medium=email&_hsmi=100194737&utm_content=100194737&utm_source=hs_email



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media